Scientific activities
... and the development of AIDS", University of Copenhagen, 1993. Publications. Author or co-author on more than 300 papers published in peer review journals. First author on 51 papers. According to Web of Science: h-index 39. Speaker at several International Conferences. Scientific activities Head of I ...
... and the development of AIDS", University of Copenhagen, 1993. Publications. Author or co-author on more than 300 papers published in peer review journals. First author on 51 papers. According to Web of Science: h-index 39. Speaker at several International Conferences. Scientific activities Head of I ...
EDUCATIONAL GOALS AND OBJECTIVES
... Develop a broad knowledge of the epidemiology of MSK disorders in society and the impact on the individuals and their families. ...
... Develop a broad knowledge of the epidemiology of MSK disorders in society and the impact on the individuals and their families. ...
Tumor Necrosis Factor Receptor Associated Periodic Syndrome
... drugs help to relieve symptoms. High dose steroids are often effective but sustained usage leads to serious side effects. Specific TNF blockade with the type II TNF receptorimmunoglobulin fusion molecule (Etanercept) has been shown to be an effective treatment in some patients for the prevention of ...
... drugs help to relieve symptoms. High dose steroids are often effective but sustained usage leads to serious side effects. Specific TNF blockade with the type II TNF receptorimmunoglobulin fusion molecule (Etanercept) has been shown to be an effective treatment in some patients for the prevention of ...
Newsletter - January 2016 - Grampians Region Health Collaborative
... recently – it is important to maintain a level of alertness as we are now faced with many emerging infectious diseases and multi resistant microorganisms. If you do not have a poster in ED please ask your ICP. ...
... recently – it is important to maintain a level of alertness as we are now faced with many emerging infectious diseases and multi resistant microorganisms. If you do not have a poster in ED please ask your ICP. ...
13063_2017_1857_MOESM2_ESM (Unknown, 34Kb)
... f. Ongoing or recent (last 12 months) evidence of active tuberculosis or known active infection (screening for tuberculosis is part of ‘standard of care’ in patients with established AAV) or evidence of untreated latent tuberculosis. Screening for tuberculosis is as per local practice. g. History of ...
... f. Ongoing or recent (last 12 months) evidence of active tuberculosis or known active infection (screening for tuberculosis is part of ‘standard of care’ in patients with established AAV) or evidence of untreated latent tuberculosis. Screening for tuberculosis is as per local practice. g. History of ...
- Thomson One
... disability has worsened over time. In MS clinical trials, it is usually measured using the Expanded Disability Status Scale (EDSS) over two time points. A 6 month measure is considered a more reliable assessment of long term disability accumulation13,14. Confirmed disability progression is a key mea ...
... disability has worsened over time. In MS clinical trials, it is usually measured using the Expanded Disability Status Scale (EDSS) over two time points. A 6 month measure is considered a more reliable assessment of long term disability accumulation13,14. Confirmed disability progression is a key mea ...
TB quick facts - WHO Western Pacific Region
... since 2006 (from 9.4 million in 2009 to 8.8 million in 2010). • 46% of HIV-positive TB patients were enrolled on antiretrovirals and 77% started ...
... since 2006 (from 9.4 million in 2009 to 8.8 million in 2010). • 46% of HIV-positive TB patients were enrolled on antiretrovirals and 77% started ...
Sample Appeal Letter – Breast Cancer
... or chemotherapy for metastatic disease. The effectiveness of PERJETA in combination with trastuzumab and docetaxel in HER2-positive metastatic breast cancer patients who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease is based on progression free survival. PERJETA is ...
... or chemotherapy for metastatic disease. The effectiveness of PERJETA in combination with trastuzumab and docetaxel in HER2-positive metastatic breast cancer patients who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease is based on progression free survival. PERJETA is ...
document - Lymphoma Coalition
... investigating the genetic basis of cancers such as lymphoma. Although the majority of these gene variants do not influence disease risk, certain SNPs may influence susceptibility to disease, disease severity, disease progression or other outcomes related to the disease. One of the biggest current ch ...
... investigating the genetic basis of cancers such as lymphoma. Although the majority of these gene variants do not influence disease risk, certain SNPs may influence susceptibility to disease, disease severity, disease progression or other outcomes related to the disease. One of the biggest current ch ...
University of California, Los Angeles UCLA Medical
... Bring a research project from inception and funding to publication over the course of the fellowship. Apply scientific understanding to the medical care of patients; understand the pathophysiology of inflammation and its relation to asthma, allergic rhinitis, chronic sinusitis, atopic dermatitis, ...
... Bring a research project from inception and funding to publication over the course of the fellowship. Apply scientific understanding to the medical care of patients; understand the pathophysiology of inflammation and its relation to asthma, allergic rhinitis, chronic sinusitis, atopic dermatitis, ...
vet_virology_symposium
... *Registration: Friday, July 11, 4:00 - 8:00 p.m. and Saturday, July 12, 7:00 - 8:20 a.m *Admittance will not be permitted without ASV meeting registration as displayed on nametags ...
... *Registration: Friday, July 11, 4:00 - 8:00 p.m. and Saturday, July 12, 7:00 - 8:20 a.m *Admittance will not be permitted without ASV meeting registration as displayed on nametags ...
Medicines in developMent Biologics
... • The first genetically engineered antibody approved to prevent the formation of new blood vessels that provide tumors with oxygen and nutrients—a process called angiogenesis. The medicine was approved for the treatment of metastatic colorectal cancer. Using angiogenesis as an approach to fight ...
... • The first genetically engineered antibody approved to prevent the formation of new blood vessels that provide tumors with oxygen and nutrients—a process called angiogenesis. The medicine was approved for the treatment of metastatic colorectal cancer. Using angiogenesis as an approach to fight ...
Core Curriculum Slides - Austin Community College
... cultures convert to negative After 3 months of therapy, if cultures are positive or symptoms do not resolve, reevaluate for Potential drug-resistant disease Nonadherence to drug regimen If cultures do not convert to negative despite 3 months of therapy, consider initiating DOT ...
... cultures convert to negative After 3 months of therapy, if cultures are positive or symptoms do not resolve, reevaluate for Potential drug-resistant disease Nonadherence to drug regimen If cultures do not convert to negative despite 3 months of therapy, consider initiating DOT ...
Multiple Sclerosis in a Primary Care Setting - Pri-Med
... CSF or Await future clinical attack implicating a different site Dissemination in time, demonstrated by: • MRI or Second clinical attack Dissemination in space, demonstrated by: • MRI or ≥2 detected lesions consistent with MS plus positive CSF and Dissemination in time, demonstrated by: • MRI or sec ...
... CSF or Await future clinical attack implicating a different site Dissemination in time, demonstrated by: • MRI or Second clinical attack Dissemination in space, demonstrated by: • MRI or ≥2 detected lesions consistent with MS plus positive CSF and Dissemination in time, demonstrated by: • MRI or sec ...
Thesis Abstract Drug hypersensitivity reactions represent a major
... In the second publication, we describe a case of fulminate liver failure after vancomycine treatment in 60-year-old patient with sulfasalazine-induced DRESS syndrome. This case report is unique, as we obtained four biopsies, before and after liver transplantation, and we could elute cells from the a ...
... In the second publication, we describe a case of fulminate liver failure after vancomycine treatment in 60-year-old patient with sulfasalazine-induced DRESS syndrome. This case report is unique, as we obtained four biopsies, before and after liver transplantation, and we could elute cells from the a ...
PowerPoint_Template - National Multiple Sclerosis Society
... 1/750 for the general population (0.1%) 1/40 for person with a close relative with MS (3%) 1/4 for an identical twin (25%) • 20% of people with MS have a blood relative with MS The risk is higher in any family in which there are several family members with the disease (aka multiplex families) ...
... 1/750 for the general population (0.1%) 1/40 for person with a close relative with MS (3%) 1/4 for an identical twin (25%) • 20% of people with MS have a blood relative with MS The risk is higher in any family in which there are several family members with the disease (aka multiplex families) ...
International Research in Infectious Diseases Annual Meeting May
... Comparison of immune responses to the O‐specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adults with cholera Feasibility study of a mass immunization program with the oral cholera vaccine Shanchol, in a high risk urban population in Dhaka city in Bangladesh A ...
... Comparison of immune responses to the O‐specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adults with cholera Feasibility study of a mass immunization program with the oral cholera vaccine Shanchol, in a high risk urban population in Dhaka city in Bangladesh A ...
Slide job
... Define disease and clinical time course – mixing together various infections makes interpretation of results challenging Differentiate treatment from prevention trials – “salvage” vs primary treatment Differentiate explanatory trials from strategy/management trials Differentiate measurement ...
... Define disease and clinical time course – mixing together various infections makes interpretation of results challenging Differentiate treatment from prevention trials – “salvage” vs primary treatment Differentiate explanatory trials from strategy/management trials Differentiate measurement ...
university of cape town
... Some prior experience of clinical research will be very advantageous. A high level of knowledge and experience in HIV and TB clinical practice is required, such that the Medical Officer could manage complex cases with HIV and TB coinfection independently. The term of the post will initially be a 6 m ...
... Some prior experience of clinical research will be very advantageous. A high level of knowledge and experience in HIV and TB clinical practice is required, such that the Medical Officer could manage complex cases with HIV and TB coinfection independently. The term of the post will initially be a 6 m ...